Mindef refers matter to AGC after doctor refused to stop patent infringement allegations

Mindef refers matter to AGC after doctor refused to stop patent infringement allegations
Dr Ting Choon Meng (left), an adjunct professor at Nanyang Technological University, and Dr Mak Koon Hou, a cardiologist, walking out of the Supreme court. They sued the Government for patent infringement, claiming Mindef had copied its concept of a mobile emergency medical station and have dropped their claim, citing financial difficulties.

SINGAPORE - The Ministry of Defence (Mindef) has issued a statement after a doctor refused to stop making allegations of patent infringement against it.

In its statement, Mindef says it had earlier clarified and provided opportunities for Dr Ting Choon Meng, co-founder of MobileStats Technologies, to stop repeating what it says are "false allegations".

The allegations are detrimental to Mindef's integrity as a government organisation, it said, adding that the accusations can dent public confidence in the Government.

Since 2011, Dr Ting has alleged that Mindef had copied his patented concept for an emergency mobile clinic. These claims were found to be untrue by the High Court in January 2014. Not only was Dr Ting's patent declared invalid and revoked, the Court also found that Mindef was not guilty of infringing intellectual property.

In the statement released on Wednesday, Mindef said that it has referred the matter to the Attorney-General's Chambers (AGC).

Mindef said: "As a government organisation, MINDEF is held to a standard of conduct that has to be no less than exemplary. When false allegations are made that impinge on our integrity, they can dent public confidence in MINDEF and the government. MINDEF takes these allegations very seriously and has provided opportunities for the false allegations to be corrected, but without success."


More about

Purchase this article for republication.



Your daily good stuff - AsiaOne stories delivered straight to your inbox
By signing up, you agree to our Privacy policy and Terms and Conditions.